Yuhan Corporation
000100
Rang in aandelen
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Aandeelprijs
$63.22
Marktkapitalisatie
$4.27B
Verandering (1 dag)
-3.12%
Verandering (1 jaar)
-23.57%
Land
KR
Handel Yuhan Corporation (000100)
Categorie
Healthcare
Operationele marge voor Yuhan Corporation (000100)
Operationele marge op October 2026 TTM: 5.46%
Volgens de meest recente financiële rapporten en aandelenkoers van Yuhan Corporation is de huidige operationele marge (TTM) 5.46%. Eind 2024 had het bedrijf een operationele marge van 2.65%.
Geschiedenis van de operationele marge van Yuhan Corporation van 2007 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 5.46% | -3.36% |
| 2025 | 5.65% | 113.21% |
| 2024 | 2.65% | -33.92% |
| 2023 | 4.01% | 97.54% |
| 2022 | 2.03% | -29.51% |
| 2021 | 2.88% | -44.62% |
| 2020 | 5.20% | 19.82% |
| 2019 | 4.34% | 31.52% |
| 2018 | 3.30% | -45.63% |
| 2017 | 6.07% | -17.97% |
| 2016 | 7.40% | -2.63% |
| 2015 | 7.60% | 3.97% |
| 2014 | 7.31% | 11.60% |
| 2013 | 6.55% | 46.86% |
| 2012 | 4.46% | -38.23% |
| 2011 | 7.22% | -42.01% |
| 2010 | 12.45% | -6.74% |
| 2009 | 13.35% | -1.69% |
| 2008 | 13.58% | -6.47% |
| 2007 | 14.52% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 19.41% | -96.45% |
DE
|
|
| 19.68% | -96.40% |
DE
|
|
| 10.52% | -98.07% |
JP
|
|
| 17.08% | -96.87% |
CH
|
|
| 22.93% | -95.80% |
IN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.